Toggle navigation
HOME
NEWSFEEDS
Healthcare Industry News
Medical Devices
Biopharmaceuticals
Diagnostics
Cardiology
Interventional
Neuro
Oncology
Orthopaedic
Surgery
People
Distribution
FDA Actions
Regulatory (INTL)
Mergers & Acquisitions
Venture Capital
INDEPENDENT REPS
For MANUFACTURERS:
Find Reps NOW
Post Your Rep Opportunity
Not sure? Let us help!
For REPS and DISTRIBUTORS:
Not in FindReps? Contact us!
ISR REGISTRY:
Independent Sales Reps - USA
Not a MEMBER Yet?
Join HSMN
FORUMS
Independent Sales Reps & Distributors
The Network Bulletin Board
Getting Started in Medical Sales
Show All Forums
RESOURCES
FindReps®
Help / FAQs
INDUSTRY LINKS:
Medical Device Companies
Biopharmaceutical Companies
Professional Organizations
Government & Regulatory
Products & Services
Venture Capital
MEMBERS
Join HSMN
Forgot Username / Password
Help / FAQs
PASSWORD REQUIRED:
Company Links Listing (Manufacturers)
Products & Services Listing (Vendors)
Post in Forums
Renew Membership
Change Password
Update Contact Info
Something else? - Contact Us
ABOUT
About HSMN
Membership Info
FindReps®
Join HSMN
Help / FAQs
Submit News Release
Info for Advertisers
Contact Us
Searching News Database:
Biosync Scientific
HSMN NewsFeed - 10 Apr 2007
MIV Therapeutics Announces Addition of Eight New Approved Products Following Recent Acquisition of India-Based Stent Manufacturer
Devices
Interventional Cardiology
HSMN NewsFeed - 9 Apr 2007
MIV Therapeutics Announces Addition of Veteran Management Team Following Recent Acquisition of India-Based Biosync Scientific
Devices
Interventional Cardiology
Personnel
HSMN NewsFeed - 5 Apr 2007
MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
Devices
Interventional Cardiology
HSMN NewsFeed - 20 Feb 2007
MIV Therapeutics Completes Acquisition of Biosync Scientific to Expand Operations and Accelerate Commercialization in Fast-Growing Markets
Devices
Interventional Cardiology
Mergers & Acquisitions
HSMN NewsFeed - 8 Jan 2007
MIV Therapeutics Executes Private Financings for $4 Million to Support Acquisitions, Development and Distribution of Next Generation Stents
Devices
Interventional Cardiology
HSMN NewsFeed - 14 Dec 2006
MIV Therapeutics Announces Market Launch of the GenX CrCo Stent and Seven Associated Interventional Cardiology Products by Biosync Scientific
Devices
Interventional Cardiology
HSMN NewsFeed - 11 Dec 2006
MIV Therapeutics Executes Milestone Agreement to Acquire Biosync Scientific, a Leading Indian Interventional Cardiology Company
Devices
Mergers & Acquisitions
Interventional Cardiology
Return to NewsFeed